Impact of Borderline Resectable Criteria on Hepatocellular Carcinoma Treatment From the Perspective of Tumor Burden
Macrovascular invasion significantly impacted prognosis in patients undergoing hepatectomy, for both BR1 and BR2, whereas any of the tumor factors did not affect the prognosis of patients receiving systemic chemotherapy. Tumor burden correlated with prognosis in the entire cohort but not in chemotherapy responders, suggesting effective treatment may overcome poor prognostic indicators.
Authors
- Eisuke Ueshima (ORCID: https://orcid.org/0000-0001-8802-8793)
- Jun Ishida (ORCID: https://orcid.org/0000-0001-7550-448X)
- Nobuaki Ishihara
- Keitaro Sofue (ORCID: https://orcid.org/0000-0001-6132-1623)
- Hidetoshi Gon (ORCID: https://orcid.org/0000-0002-4338-6084)
- Masaki Omori
- Yuzo Kodama (ORCID: https://orcid.org/0000-0002-1741-5638)
- Yoshimi Fujishima
- Takumi Fukumoto
- Hiroaki Yanagimoto
- Masahiro Kido
- Shohei Komatsu
- Yoshihide Nanno
- Toshifumi Tada
- Kenji Fukushima
- Takanori Matsuura
- Takeshi Urade
Institutions
- Kobe Medical Center (JP)
- Kobe University Hospital (JP)
- Kobe University (JP)
Publication Details
- Journal
- World Journal of Surgery
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1002/wjs.70287
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00